Robert Owens, MD
Otology & Neurotology · Plano, TXNPI 1194792739
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,700 of the $7,367 with a category attached, or 90.9%. Lumenis, Inc accounts for 90.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $5,257 and has fallen 89.2% since, to $569 in 2022. Among otology & neurotology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 13 payments — averaging $566.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis, Inc$7K
- Medical Device Business Services, Inc.$569
- Acclarent, Inc$61
- Cochlear Americas$38
What the payments were for
- Speaking & faculty fees$6,70091%
- Travel & lodging$5077%
- Food & beverage$1562%
- Gifts$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis, Inc | 2 | $6,700 |
| Medical Device Business Services, Inc. | 7 | $569 |
| Acclarent, Inc | 2 | $61 |
| Cochlear Americas | 2 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lumenis Pulse 120H$1,500
How this compares
$7,367 in reported general payments places this provider in the 90th percentile of 33 otology & neurotology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 36 | $3,937 |
| Epinephrine | 14 | $2,523 |
| Diazepam | 214 | $1,381 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 41 | $415 |
| Glycopyrrolate | 12 | $269 |
| Ondansetron OdtOndansetron | 27 | $231 |
| Amoxicillin | 52 | $132 |
| Methylprednisolone | 15 | $91 |
| Montelukast Sodium | 12 | $49 |
Paid to pharmacies, not to this prescriber.
Other otology & neurotology in Plano
- Brandon IsaacsonDallas$98K
- Joe KutzDallas$95K
- Chester StrunkWebster$8K
- James DanielsDallas$7K
- Vivian KaulHouston$6K
- Mark NicholsHouston$5K
- Jonathan ChoiAustin$4K
- Jason AdamsJbsa Ft Sam Houston$3K
- Susan KingSan Antonio$3K
- Cherie BoothMcKinney$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.